Another possibility is the over-expression of soluble molecules that inhibit or decrease metastasis in melanoma, including PF4/CXCL4, TR47, and MMP8, which could be used in combination with CAR T cells that target surface molecules. The gene discussed is MMP8; the disease is melanoma.